BRIEF published on 08/18/2025 at 23:35, 6 months 1 day ago Medicure annoncera ses résultats financiers du deuxième trimestre 2025 par conférence téléphonique Résultats Financiers Conférence Téléphonique Médicaments Medicure T2 2025
PRESS RELEASE published on 08/18/2025 at 23:30, 6 months 1 day ago Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025 Medicure Inc. to present Financial Results for Q2 2025 on August 21, 2025 via conference call. Operations and products focus detailed Financial Results Conference Call Pharmaceuticals Medicure Inc. Healthcare Products
BRIEF published on 06/17/2025 at 23:05, 8 months 2 days ago Medicure finalise l'acquisition de la pharmacie West Olympia Acquisition Croissance Des Revenus Médicaments Medicure Pharmacie
BRIEF published on 06/17/2025 at 23:05, 8 months 2 days ago Medicure Finalizes Acquisition of West Olympia Pharmacy Acquisition Revenue Growth Pharmaceuticals Pharmacy Medicure
PRESS RELEASE published on 06/17/2025 at 23:00, 8 months 2 days ago Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
BRIEF published on 05/21/2025 at 23:05, 8 months 29 days ago Medicure annonce ses résultats financiers du premier trimestre 2025 et les résultats de l'élection des administrateurs Perte Nette Élection Du Directeur Résultats Financiers De Medicure Baisse Des Ventes D'AGGRASTAT Revenus Des Pharmacies
BRIEF published on 05/21/2025 at 23:05, 8 months 29 days ago Medicure Announces Q1 2025 Financial Results and Director Election Outcomes Net Loss Director Election Medicure Financial Results AGGRASTAT Sales Decline Pharmacy Revenue
PRESS RELEASE published on 05/21/2025 at 23:00, 8 months 29 days ago Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results Medicure Inc. reports Q1 2025 results with $5.5M net revenue, elects directors, and details financial performance. AGGRASTAT and ZYPITAMAG sales analyzed Medicure Inc. Net Revenue AGGRASTAT ZYPITAMAG Q1 2025 Results
BRIEF published on 04/25/2025 at 23:06, 9 months 24 days ago Medicure Inc. Reveals Financial Results for 2024 Medicure Inc. 2024 AGGRASTAT® Sales ZYPITAMAG® Revenue Marley Drug Financials Adjusted EBITDA Decline
BRIEF published on 04/25/2025 at 23:06, 9 months 24 days ago Medicure Inc. dévoile ses résultats financiers pour 2024 Medicure Inc. 2024 Marley Drug Financials Ventes D'AGGRASTAT® Chiffre D'affaires De ZYPITAMAG® Baisse De L'EBITDA Ajusté
Published on 02/20/2026 at 18:30, 18 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 3 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 18 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 40 minutes ago Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 48 minutes ago Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors
Published on 02/20/2026 at 18:36, 12 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 17 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 48 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 48 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 09:28, 9 hours 20 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 20 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026
